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Background: Genetic polymorphisms, gender and age all influence the risk of developing chronic neuropathic pain
following peripheral nerve injury (PNI). It is known that there are significant inter-strain differences in pain hypersensitivity
in strains of mice after PNI. In response to PNI, one of the earliest events is thought to be the disruption of the blood-
spinal cord barrier (BSCB). The study of BSCB integrity after PNI may lead to a better understanding of the mechanisms
that contribute to chronic pain.
Results: Here we used in vivo dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to establish a
timecourse for BSCB permeability following PNI, produced by performing a spared nerve injury (SNI). From this
longitudinal study, we found that the SNI group had a significant increase in BSCB permeability over time throughout
the entire spinal cord. The BSCB opening had a delayed onset and the increase in permeability was transient, returning
to control levels just over one day after the surgery. We also examined inter-strain differences in BSCB permeability
using five mouse strains (B10, C57BL/6J, CD-1, A/J and BALB/c) that spanned the range of pain hypersensitivity. We
found a significant increase in BSCB permeability in the SNI group that was dependent on strain but that did not
correlate with the reported strain differences in PNI-induced tactile hypersensitivity. These results were consistent with a
previous experiment using Evans Blue dye to independently assess the status of the BSCB permeability.
Conclusions: DCE-MRI provides a sensitive and non-invasive method to follow BSCB permeability in the same group of
mice over time. Examining differences between mouse strains, we demonstrated that there is an important genetically-
based control of the PNI-induced increase in BSCB permeability and that the critical genetic determinants of BSCB
opening after PNI are distinct from those that determine genetic variability in PNI-induced pain hypersensitivity.
Keywords: Blood-spinal cord barrier permeability, Dynamic contrast-enhanced MRI, Gd-DTPA, Mouse, Neuropathic pain,
Peripheral nerve injury, Spinal cordBackground
Peripheral nerve injury (PNI) is estimated to affect 3-8%
of people worldwide and often leads to chronic neuro-
pathic pain [1]. The neuropathic pain phenotype varies
widely in both humans and rodent strains, with genetic
polymorphisms, gender and age all influencing the risk
of developing and the intensity of persistent pain [2,3].
In response to PNI, a cascade of cellular and molecular
changes occurs, with disruption of the blood-spinal cord
barrier (BSCB) thought to be one of the earliest events.
The BSCB is a network of endothelial cells joined by* Correspondence: lcahill@mouseimaging.ca
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unless otherwise stated.tight junctions that acts as an interface protecting the
spinal cord parenchyma from the circulation and the
periphery. Dysfunction of the BSCB may allow penetra-
tion of inflammatory cells (e.g. monocytes) and immune
cells (e.g. T cells) and is thought to play an important
role in disorders such as traumatic brain/spinal cord in-
jury, stroke and neurodegeneration [2,4]. The study of
BSCB integrity after PNI may lead to the development
of a better understanding of the mechanisms that con-
tribute to chronic pain.
Using intravenously administered Evans Blue dye, we
have shown PNI injury causes delayed opening of the
BSCB, triggered by discharge activity in TRPV1-
expressing C-fibers [5]. The use of tracers such as Evans
Blue to assess BSCB integrity requires a cross-sectionaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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enhanced magnetic resonance imaging (DCE-MRI) pro-
vides a non-invasive and quantitative technique for
assessing BSCB permeability. The BSCB is normally im-
permeable to paramagnetic MR contrast agents such as
Gd-DTPA. If the BSCB is disrupted, Gd-DTPA can leak
into the spinal cord, causing it to appear hyperintense in
T1-weighted MR images. This technique has been used
to investigate BSCB disruption following mechanical
spinal cord injury in the rat [6-10] and mouse [11], in
animal models of amyotrophic lateral sclerosis [12] and
in mice with experimental autoimmune encephalomyeli-
tis (EAE) [13,14]. An increased BSCB permeability has
been correlated to behavioural metrics such as deterio-
rated motor function [7,9].
In the present study, we performed spared nerve injury
(SNI) in mice, a robust model in which the tibial and
common peroneal nerves are injured and that closely
mimics many clinical features of neuropathic pain
[15,16]. Using in vivo DCE-MRI, we examined BSCB in-
tegrity in a group of SNI and control mice over time.
After establishing a timecourse for BSCB permeability,
we investigated whether BSCB opening is necessary for
pain hypersensitivity. A common symptom of neuro-
pathic pain is hypersensitivity to normally innocuous
stimuli, a phenomenon known as mechanical allodynia
[17]. A recent study found significant inter-strain differ-
ences in tactile hypersensitivity in 18 inbred strains of
mice after PNI [18]. Using a genome-wide linkage ana-
lysis, they identified a haplotype in the P2RX7 gene that
affects chronic pain sensitivity in both mice and humans.
Based on this work, we chose four inbred, and one out-
bred (CD-1), mouse strains that spanned the range of
pain hypersensitivity, from least (B10) to most (BALB/c)
allodynia, and used DCE-MRI to look at inter-strain dif-
ferences in BSCB permeability.
Results
We assessed the integrity of the BSCB by administering
the MR contrast agent Gd-DTPA (Magnevist). A com-
promised BSCB permits the leakage of contrast agent
into the spinal cord and the increase in signal intensityFigure 1 Transverse T1-weighted MR images of the mouse spinal cor
injection of Gd-DTPA and (b) after injection of Gd-DTPA; (c) a control CD-1
These images illustrate the inherently low spatial resolution of in vivo MRIin T1-weighted MR images is indicative of the concen-
tration of contrast agent in the tissue, providing a rela-
tive measure of BSCB permeability [19]. The periphery
of the entire spinal cord, as well as the boundaries of the
grey and white matter within the anterior of the lumbar
cord, are readily delineated on a conventional in vivo T1-
weighted MRI scan with 100 μm resolution (Figure 1).
This quality of anatomical definition resulted in a low in-
terobserver variability of less than 2% for the measure-
ment of normalized spine signal intensity across all
studies. Representative transverse slices through the
lumbar spinal cord before and after administration of the
contrast agent are shown in Figure 1a and 1b. Before ad-
ministration of the contrast agent, there was no difference
in the normalized spine signal intensity between treatment
groups (SNI or control), over time for the longitudinal
study and between mouse strains for the study of strain
differences (Additional file 1). Following successful injec-
tion of the contrast agent, the surrounding cerebrospinal
fluid (CSF) and tissue consistently showed elevated signal
intensity. In addition, a weak positive correlation was
found between the normalized spine signal intensity and
normalized muscle signal intensity (adjusted R2 = 0.27).
Thus, a calibration exercise was performed to account for
factors that could contribute to the variability in the nor-
malized spine signal intensity (i.e. differences in the tip
angle of the magnetization). Here, correcting for the cor-
relation between spinal cord signal and muscle did not re-
duce the variability in the data so it was not included as a
factor. In all of the studies, signal enhancement following
Gd-DTPA injection was found throughout the spinal cord
but was more pronounced at the periphery of the cord.
Longitudinal Study: BSCB permeability is increased in
CD-1 mice following SNI
Representative transverse slices through the lumbar
spinal cord in control and SNI CD-1 mice are shown in
Figure 1c and 1d. Longitudinal assessment of the perme-
ability of the BSCB in CD-1 mice revealed a significant
difference in normalized spine signal intensity over time
between the SNI and control groups (p = 3.8×10−6,
Kruskal-Wallis test, Figure 2 right). In the SNI group,d. (a) A BALB/c mouse from the control treatment group before
mouse and (d) a SNI CD-1 mouse at 29.5 hours after the surgery.




















































Figure 2 SNI causes delayed opening of the BSCB in CD-1 mice. A longitudinal study using DCE-MRI to follow BSCB permeability over time
(hours post-surgery) in SNI (red) and control (blue) treatment groups. Left panel shows the mean data averaged over the thoracic and lumbar
ROIs. The error bars represent 90% confidence intervals determined by bootstrap resampling of ROI intensity values at each time point; *p < 0.05
compared to controls. Right panel shows the data fitted with a linear mixed effects model, assuming a constant intensity for control mice and
modeling intensity deviations in SNI mice with a natural spline consisting of two internal knot points (after logarithmically scaling time). The mean
data points are shown after removal of per subject random effects and the grey shaded regions illustrate 90% confidence intervals determined
by bootstrap resampling of subjects.
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sity at 9.5 and 21 hours after surgery as compared with
controls (p = 0.0058 and 0.00026 respectively, t-test)
(Figure 2 left). The increase in signal intensity was found
in both the thoracic and lumbar segments of the spinal
cord even though the injury was localized to the primary
afferent neurons in the lumbar segment. However, by
29.5 hours after surgery the signal intensity in the SNI
group no longer differed from that of controls and there
was a small but significant decrease by 172 hours (p =
0.031, t-test). From this longitudinal study, we conclude
that the BSCB permeability has a delayed onset and that
the increase in permeability is transient, returning to
control levels 29.5 hours after the surgery.
Strain Differences: BSCB permeability is increased in both
CD-1 and A/J mice following SNI
Based on the peak in normalized spine signal intensity
in the longitudinal study using CD-1 mice, we chose a
time point of approximately 12 hours after the surgery
to investigate whether there is an effect of strain on the
BSCB permeability. Figure 3 left shows the normalized
spine signal intensity in five strains (B10, C57BL/6J,
CD1, A/J and BALB/c), after administration of Gd-
DTPA. The mouse strains are ordered from least to
most PNI-induced allodynia, determined by their hind-
paw withdrawal thresholds to von Frey filament stimula-
tion (Figure 4). Overall, there was a significant increase
in normalized spine signal intensity in the SNI group(treatment: p = 3.1×10−4, two-way ANOVA) that was
dependent on strain (strain: p = 0.010, two-way ANOVA)
and had a significant interaction between treatment
group and strain (treatment x strain: p = 0.0016, two-
way ANOVA). In addition to the increase in signal in-
tensity in the CD-1 cohort observed in the longitudinal
study (p = 0.0058, t-test), the A/J mice also showed a sig-
nificant increase in BSCB permeability compared to con-
trols (p = 0.0026, t-test). This result was consistent with
a separate experiment using the Evans Blue assay to in-
dependently assess the status of the relative BSCB per-
meability in the same five strains of mice (Figure 3
right). There was a statistically significant increase in Ev-
ans Blue dye in the SNI group (treatment: p = 0.001,
two-way ANOVA) that was dependent on strain (strain:
p = 0.028, two-way ANOVA) and had a significant inter-
action between treatment group and strain (treatment x
strain: p = 0.005, two-way ANOVA). The SNI group for
the CD-1 and A/J mice showed the largest effects and a
significant increase in accumulation of the Evans Blue
dye as compared with controls (p = 0.018 and 0.027 re-
spectively, t-test).
Discussion
The BSCB is highly restrictive and both Gd-DTPA and
Evans Blue bound to albumin are of sufficient molecular
size to be impermeable to the intact BSCB (0.94 and
68 kDa respectively). If the BSCB is disrupted, these




















































Figure 3 Strain-related differences in BSCB permeability. Left panel shows normalized spine signal intensity in SNI (grey bars) and control (white
bars) treatment groups at approximately 12 hours after surgery (n = 4–6 per group, except for CD-1: n = 2–3 per group). Right panel shows accumulation
of Evans Blue dye in a separate cohort of SNI (grey bars) and control (white bars) treatment groups 24 hours after surgery (n = 5 per group). The mouse
strains are ordered from least to most mechanical hypersensitivity after PNI. Data are presented as mean ± SEM; *p < 0.05 compared to controls.
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non-invasive and quantitative method for measuring
BSCB permeability while the use of Evans Blue is pri-
marily a qualitative histological technique. There are
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Figure 4 Strain differences in BSCB permeability did not correlate
with strain differences in PNI-induced tactile hypersensitivity. Plot
of the normalized spine signal intensity difference between SNI and
control with the percentage of the maximum possible allodynia in five
mouse strains (B10, C57BL/6J, CD-1, A/J and BALB/c) (n = 6 per group,
except CD-1: n = 11 per group) (p = 0.232).Gd-DTPA and Evans Blue, which have been used to study
the permeability of the BSCB. These include small mo-
lecular tracers such as [14C]-alpha-aminoisobutyric acid
(AIB, 0.1 kDa) [20] and large proteins such as immuno-
globulin G (IgG, 160 kDa) [13].
Compared to the use of traditional invasive or terminal
histological techniques, longitudinal DCE-MRI studies
provide a probe of the temporal and spatial changes in
the BSCB permeability within a single animal. There are
several longitudinal studies in the literature that have
used DCE-MRI to examine BSCB permeability in ro-
dents. Our observation of increased BSCB disruption in
the white matter compared to the grey matter is consist-
ent with the work of Schellenberg et al. in a model of
EAE [13]. This may reflect the fact that damage to the
white matter following spinal cord injury is thought to
be responsible for persistent functional loss [21]. Inter-
estingly, the magnitude of the increases in BSCB perme-
ability that we observed in this study (<20%) was quite
subtle in comparison to other reports. For example, in
mouse models of EAE, changes of greater than 60% have
been observed [13,14]. This is consistent with EAE as a
direct insult to the spinal cord while changes in the cord
following PNI is secondary to pain.
The finding of a delay in the opening of the BSCB and
the return to control levels in CD-1 mice is consistent
with our previous work in rats following SNI [5]. This
cross-sectional design revealed a peak in Evans Blue dye
at 24 hours after surgery. The fact that we observed a
peak in signal intensity at an earlier time point could be
attributed to the fact that Gd-DTPA has a significantly
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min (0.94 and 68 kDa respectively). Thus, MR contrast
agents are more sensitive to detecting early BSCB break-
down than histological techniques such as the Evans
Blue assay. This difference could also be explained by
the species differences since BSCB permeability has been
reported to be greater in rats than in mice [22]. This
was consistent with our examination of strain differ-
ences, where the largest accumulation of Evans Blue dye
was 3.1 μg/g in the CD-1 mice compared to approxi-
mately 10 μg/g in rats [5].
Also consistent with our previous findings [5], we ob-
served here that the increase in BSCB permeability mea-
sured by Gd-DTPA was along the spinal cord and was
not limited to the lumbar segments. Thus in both rats
and mice PNI causes an increase in BSCB permeability
that extends well beyond the central termination of the
injured primary afferent neurons. Previously, we had
found that in rats the increase in permeability extends
into regions of the brain as well as the spinal cord [5].
Given our previous findings, we expect that the blood–
brain barrier permeability as well as the BSCB perme-
ability were increased by PNI in mice. The widespread
increase in CNS vascular permeability might involve
production and release of a humoral mediator, or media-
tors, that act on the cellular and/or intercellular ele-
ments that maintain the intact barrier [5]. Alternatively,
there might be spread of BSCB permeability from an ini-
tiation site in the lumbar spinal cord or central release
of diffusible mediator(s) that circulate within the cere-
brospinal fluid. The widespread increase in permeability
contrasts with the activation of microglia cells following
PNI [23], cells that are key intermediaries in PNI-
induced pain hypersensitivity [24].
We found concordance between the MRI and Evans
Blue results in terms of which strains showed PNI-
induced significant increase in BSCB permeability. How-
ever, the strain differences did not correlate with strain dif-
ferences in PNI-induced tactile hypersensitivity (Figure 4)
[18]. For example, BALB/c mice showed the highest tactile
hypersensitivity in this group yet there was no significant
difference in normalized spine signal intensity or accumu-
lation of Evans Blue in the SNI treatment group compared
to controls. Thus, an increase in BSCB permeability after
PNI might not be required for PNI-induced tactile hyper-
sensitivity. Although, it is possible that there was PNI-
induced opening of the BSCB in the other strains but that
was not detected by the single-time point measurement
we used. Evaluating this possibility would require a
complete longitudinal study for each strain.
Nevertheless, the differences we did observe between
the mouse strains, even though only a small number of
strains were examined, demonstrate that there is import-
ant genetically-based control of the PNI-induced increasein BSCB permeability. Moreover, our findings suggest that
the critical genetic determinants of BSCB opening after
PNI are distinct from those that determine genetic vari-
ability in PNI-induced pain hypersensitivity. Identifying
the critical genes controlling variability in BSCB opening
after PNI will require larger numbers of inbred strains
than used currently and quantitative trait locus mapping,
as has been done for PNI-induced pain hypersensitivity
(e.g. [18]) and other complex traits. Finally, the mice in-
cluded in this study were all male and it would be valu-
able to investigate whether our strain-related findings are
consistent in female mice and how BSCB permeability
differs with gender since it is well-known that gender is
a key factor for chronic neuropathic pain.
Conclusions
Here, we demonstrate that DCE-MRI is a safe, non-
invasive and quantitative method to follow BSCB perme-
ability in the same group of mice over time. After PNI,
BSCB opening is delayed by several hours, and is transi-
ent lasting just over one day before returning to control
levels. We found strain-related differences in PNI-
induced increase BSCB permeability. The between-strain
changes in BSCB permeability did not correlate with be-
havioural measures of pain hypersensitivity, suggesting
that there are critical genetic determinants of BSCB
opening after PNI which are distinct from those that de-
termine genetic variability in PNI-induced pain hyper-
sensitivity. Thus, DCE-MRI provides a sensitive and
non-invasive measure of BSCB permeability that will be




Two cohorts of male Crl:CD1(ICR) (CD-1) mice (six
SNI and four controls at 4–5 weeks of age) from Charles
River Laboratories (St. Constant, QC, Canada) were im-
aged longitudinally. MRI was performed at 6.5, 9.5, 21,
29.5, 73, 75.5 and 172 hours after surgery. To explore
strain related effects, B10.D2-HcoH2dH2-T18c/oSnJ (B10),
C57BL/6J, A/J and BALB/c mice from Jackson Laborator-
ies (Bar Harbor, ME, USA) were imaged at one time point,
approximately 12 hours after surgery (six SNI and four
controls at 5–12 weeks of age). Animal experiments were
approved by the Toronto Centre for Phenogenomics Ani-
mal Care Committee.
Peripheral nerve injury model
Spared nerve injury was performed as described previ-
ously [15,25]. Briefly, mice were anesthetized by isoflur-
ane inhalation and the left sciatic nerve exposed under
aseptic conditions. The distal trifurcation of the sciatic
nerve was identified and the tibial and common peroneal
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The wound was sutured closed and the animals allowed
to recover and returned to their housing.
von Frey Testing
Von Frey testing for mechanical allodynia following SNI
was performed as described previously [18,26]. Briefly,
von Frey fibers were applied to the lateral aspect of the
plantar hindpaw in a separate cohort of adult B10,
C57BL/6J, A/J, BALB/c and CD-1 mice (n = 6 per strain,
except for CD-1: n = 11). The up-down Dixon was used
to estimate 50% withdrawal thresholds. In later experi-
ments, an automated von Frey test (UgoBasile Dynamic
Plantar Aesthesiometer) was used. Three separate
threshold determinations were made on each hindpaw,
and then the measurements were averaged.
Magnetic resonance imaging
A multi-channel 7.0 T, 40 cm diameter bore magnet
(Varian Inc. Palo Alto, CA) and 3 cm inner diameter
Millipede RF coils (Varian NMR Systems, Palo Alto, CA)
were used to acquire in vivo 2D transverse T1-weighted
MR images of the thoracic and lumbar spinal cord in
multiple mice simultaneously [27]. The imaging protocol
consisted of a spin echo sequence with the following pa-
rameters: TR = 500 ms, TE = 10 ms, slice thickness =
3 mm, NEX = 8, field-of-view (FOV) = 3.5 × 3.5 cm and
matrix size = 350 × 350, producing an image with
100 μm in-plane resolution and an average signal-to-
noise ratio of 135 for the spinal cord. The scan time was
23 minutes per slice with three slices acquired sequen-
tially both before and after administration of the con-
trast agent. Slice localization was accomplished using a
sagittal MR image and effort was made to avoid position-
ing the slices through the lungs to minimize movement ar-
tifacts. Mice were injected with a bolus of Gd-DTPA
intraperitoneally (1.5 mmol/kg) and the imaging session
began 45 minutes after the injection. Mice were imaged
using 1–1.5% isoflurane and kept warm during the scan
using warm air, with breathing monitored continuously
according to established protocols.
Evans blue assay
Blood spinal cord permeability was determined by Evans
Blue extravasation into the spinal cord in a separate co-
hort of male B10, C57BL/6J, A/J, BALB/c and CD-1
mice (five SNI and five controls) 24 hours after injury.
Evan’s Blue dye (2%, 4 mL/kg, Sigma-Aldrich) was in-
fused through the tail vein of anesthetized mice. After
two hours animals were perfused with PBS. The spinal
cords were immediately dissected and the dura mater re-
moved. The lumbar and thoracic spinal cord tissue were
further dissected, weighed and incubated in formamide
(Sigma-Aldrich) at 60°C for 72 hrs. The Evan’s Blueconcentration was then determined by spectrophotom-
etry at 620 nm in a 96-well plate reader.
Data analysis
Regions-of-interest (ROIs) were chosen to include the
entire spinal cord. For each animal, ROIs were measured
for one thoracic and two lumbar segments of the cord.
Quantitative measurements of signal intensity were de-
termined by normalizing the spinal cord intensity to the
average intensity of two phantoms included in each coil
(microcapillary tubes containing 1% Gd-DTPA in agar).
When the difference in signal intensity between the two
phantoms was greater than 10%, attributed to damage to
the phantoms or B1 field inhomogeneity, the data set
was excluded from the analysis. Approximately 15% of
measured data was excluded. The ROI placement and
signal assessment was performed manually by two inves-
tigators and the results averaged. Interobserver variabil-
ity was expressed as the percent discrepancy between
two measurements.
Statistical analysis
All statistical tests were performed using R statistical
software (www.r-project.org). For the longitudinal study,
a Kruskal-Wallis test was used to determine if there
were differences between the treatment groups over
time, followed by t-tests to compare the groups at each
time point. To fit the data, a linear mixed effects model
was used. For the study of strain differences, data from
both DCE-MRI and the Evans Blue assay was analyzed
using t-tests to compare the effect of treatment group
for each strain and using a two-way ANOVA with treat-
ment group (SNI or control) and strain (B10, C57BL/6J,
A/J, BALB/c or CD-1) as between-subject variables. Data
from each group of animals are reported as the mean ±
standard error of the mean (SEM).
Additional file
Additional file 1: Before administration of contrast agent, there is
no difference in normalized spine signal intensity. The normalized
spine signal intensity in SNI (red) and control (blue) treatment groups
before administration of contrast agent for the longitudinal study in CD-1
mice (left panel) and for the study of strain differences (right panel). The
mean data is averaged over the thoracic and lumbar ROIs. The error bars
illustrate 90% confidence intervals determined by bootstrap resampling
of ROI intensity values. The black lines and grey shaded regions illustrate
the mean and standard deviation of the combined data.
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